Pancreatic Cancer Research

ResearcherSt. Jude Children's Research HospitalActive in the last 2 years

Mohammad Aslam Khan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1778-4086; OpenAlex author ID A5070123419. Sources: OpenAlex.

Their work

Papers
11 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2015: 2 papers · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: 3 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 11

  1. MYB and HIF1α crosstalk drives hypoxia-induced transcriptional reprogramming and adaptive signaling alterations in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2025.217916↗
  2. Mitochondrial Translocase TOMM22 Is Overexpressed in Pancreatic Cancer and Promotes Aggressive Growth by Modulating Mitochondrial Protein Import and Function. Co-author DOI 10.1158/1541-7786.mcr-23-0138↗
  3. MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming. First author DOI 10.15252/embr.202255643↗
  4. Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential diagnostic applications in pancreatic aden… Co-author DOI 10.1038/s41598-022-22006-5↗
  5. Hypoxia alters the release and size distribution of extracellular vesicles in pancreatic cancer cells to support their adaptive survival. Co-author DOI 10.1002/jcb.29328↗
  6. Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancer. Co-author DOI 10.1074/jbc.ra119.011748↗
  7. Comprehensive Analysis of Expression, Clinicopathological Association and Potential Prognostic Significance of RABs in Pancreatic Cancer. First author DOI 10.3390/ijms21155580↗
  8. Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enz… First author DOI 10.1038/bjc.2017.18↗
  9. Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward. Co-author DOI 10.3390/ijms18040779↗
  10. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy. Co-author DOI 10.1007/978-3-319-23730-5_5↗
  11. Gemcitabine triggers angiogenesis-promoting molecular signals in pancreatic cancer cells: Therapeutic implications. Co-author DOI 10.18632/oncotarget.3784↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Seema Singh · 11 shared papers, 2015–2025 · strength 1.55
  2. Ajay P. Singh · 10 shared papers, 2015–2024 · strength 1.22
  3. Shashi Anand · 5 shared papers, 2020–2025 · strength 1.03
  4. Kunwar Somesh Vikramdeo · 4 shared papers, 2022–2025 · strength 0.90
  5. Moh'd M. Khushman · 5 shared papers, 2017–2022 · strength 0.55
  6. Santanu Dasgupta · 3 shared papers, 2020–2024 · strength 0.53
  7. Sanjeev K. Srivastava · 5 shared papers, 2015–2023 · strength 0.47
  8. Ajay Pratap Singh · 1 shared paper, 2025 · strength 0.33
  9. Girijesh Kumar Patel · 3 shared papers, 2017–2020 · strength 0.25
  10. Shafquat Azim · 2 shared papers, 2017–2023 · strength 0.25
  11. Mary Oluwadamilola Haastrup · 1 shared paper, 2024 · strength 0.23
  12. Mary C. Patton · 2 shared papers, 2017–2020 · strength 0.22
  13. Arun Bhardwaj · 3 shared papers, 2015–2017 · strength 0.20
  14. Sachin Kumar Deshmukh · 1 shared paper, 2023 · strength 0.18
  15. Martin J. Heslin · 1 shared paper, 2022 · strength 0.16
  16. Sumit Arora · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.